Michael Winlo

Chief Scientific Officer / Emyria

Most Notable Role

Dr Michael Winlo, chief executive of Emerald Clinics since August 2019, was chief executive of Linear Clinical Research for 3 years and remained on the board from July 2019 when he stepped down from the CEO role to lead a startup company in digital health innovation. Linear Clinical Research is the clinical trials arm of the Harry Perkins Institute of Medical Research.

He was a co-founder of medical device startup Cerulean Medical in 2007, and spent five years in the US growing the health practice of data analysis firm Palantir Technologies.

Dr Winlo holds a Bachelor of Medicine and Surgery from the University of Western Australia, and an MBA from the Stanford Graduate School of Business.

Lists and Charts

Revenue

Rank	Company	#
117^th	Emyria	$4.82m
124^th	Nuheara	$3.87m
125^th	ResApp Health	$3.81m
126^th	Katana Capital	$3.71m
127^th	Artrya	$3.69m

194 public companies - industrial WA ranked by total revenue

View Full List

Roles

2025

Chief Scientific Officer

Emyria

2023

Non-Executive Director

Nanoveu

2023

Non-Executive Director

Dorsavi

Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
1424^th	VRX Silica">VRX Silica	-45.28%	-12.17%
1425^th	RMA Global">RMA Global	-45.48%	-35.15%
1426^th	Emyria">Emyria	-45.7%	0%
1427^th	Strike Resources">Strike Resources	-45.75%	-9.14%
1428^th	Next Science">Next Science	-45.84%	-43.04%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

	NEWS: Tagged in Board moves January 23, 2025	23 Jan 2025
	NEW ROLE: Chief Scientific Officer, Emyria	23 Jan 2025
	NEW ROLE: Non-Executive Director, Dorsavi	25 Jul 2024
	NEW ROLE: Non-Executive Director, Nanoveu	28 Mar 2023
	NEWS: Tagged in Healthtech banks on rising numbers	07 Nov 2022

Sponsored Content

Loading
Tuesday, 20 March, 2018 - 12:29
Biotech investment delivers boon to WA trial facility
If you’re suffering from advanced stages of cancer the best news your oncologist can deliver, apart from saying you’re winning the battle, is that you’re eligible for a promising new drug trial.Drug trials offer hope when other treatments have failed.

Next
Date

Previous
Date
TimelineJS
Biotech investment delivers boon to WA trial facility
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Dec. 19
Dec. 20
Dec. 21
Dec. 22
Dec. 23
Dec. 24
Dec. 25
Dec. 26
Dec. 27
Dec. 28
Dec. 29
Dec. 30
Dec. 31
Jan. 2
Jan. 3
Jan. 4
Jan. 5
Jan. 6
Jan. 7
Jan. 8
Jan. 9
Jan. 10
Jan. 11
Jan. 12
Jan. 13
Jan. 14
Jan. 15
Jan. 16
Jan. 17
Jan. 18
Jan. 19
Jan. 20
Jan. 21
Jan. 22
Jan. 23
Jan. 24
Jan. 25
Jan. 26
Jan. 27
Jan. 28
Jan. 29
Jan. 30
Jan. 31
Feb. 2
Feb. 3
Feb. 4
Feb. 5
Feb. 6
Feb. 7
Feb. 8
Feb. 9
Feb. 10
Feb. 11
Feb. 12
Feb. 13
Feb. 14
Feb. 15
Feb. 16
Feb. 17
Feb. 18
Feb. 19
Feb. 20
Feb. 21
Feb. 22
Feb. 23
Feb. 24
Feb. 25
Feb. 26
Feb. 27
Feb. 28
March 2
March 3
March 4
March 5
March 6
March 7
March 8
March 9
March 10
March 11
March 12
March 13
March 14
March 15
March 16
March 17
March 18
March 19
March 20
March 21
March 22
March 23
March 24
March 25
March 26
March 27
March 28
March 29
March 30
March 31
April 2
April 3
April 4
April 5
April 6
April 7
April 8
April 9
April 10
April 11
April 12
April 13
April 14
April 15
April 16
April 17
April 18
April 19
April 20
April 21
April 22
April 23
April 24
April 25
April 26
April 27
April 28
April 29
April 30
May 2
May 3
May 4
May 5
May 6
May 7
May 8
May 9
May 10
May 11
May 12
May 13
May 14
May 15
May 16
May 17
May 18
May 19
May 20
May 21
May 22
May 23
May 24
May 25
May 26
May 27
May 28
May 29
May 30
May 31
June 2
June 3
June 4
June 5
June 6
June 7
June 8
June 9
June 10
June 11
June 12
June 13
June 14
June 15
June 16
June 17
June 18
June 19
News Articles

Monday, 18 April, 2016 - 12:51
New CEO aims to grow Perkins subsidiary
Young medical entrepreneur Michael Winlo has returned from New York with plans to expand a unique clinical testing business in Nedlands.
Loading
Monday, 8 August, 2016 - 15:37
Turning innovative ideas into real-world outcomes
SPECIAL REPORT: Former mining boss Charlie Bass and surgeon Peter Santa Maria are among the growing number of people in Western Australia looking to make innovation a commercial reality.
Thursday, 3 November, 2016 - 14:13
Export awards show local diversity
Medical not-for-profit company Linear Clinical Research was among a diverse group of businesses to win plaudits at the recent WA Industry and Export Awards.
Friday, 29 September, 2017 - 09:50
A Linear approach to medical data
A Perth clinical trials company has introduced cloud-based technology to accelerate the development of drug therapies.
Friday, 8 December, 2017 - 14:06
Linear recognised for global growth
Nedlands-based Linear Clinical Research has won the national Business Services Award at the Australian Export Awards this week, with the judges noting its impressive growth in US projects and ability to leverages advantages in the domestic market to underpin its export success.
Thursday, 11 July, 2019 - 15:53
Appointments July 11, 2019
Our weekly appointment wrap includes Scott Jones, Terry Waldron, Reg Howard-Smith, David Buckingham, Philip Mirams, Colin Pavlovich, Ken Michael, Lee Broomhall, Kelly Howlett, Tim Youe, Joshua Byrne, David Templeman, Anne Banks-McAllister, Peter Snowsill, Martin Hirsch, Michael Winlo, Charles Fear, Patrick Beilby, Biljana Radulovic, Hector West, Matthew Seabrook, Arash Kalani, Simon Pigliardo, Kathy Reid, Melissa Joyce, Nada Raphael, Fredrick Riebeling, Gina Nofal, and Nicola Jansen.
Loading
Thursday, 3 October, 2019 - 10:53
Winlo joins Emerald Clinics
Medicinal cannabis research company Emerald Clinics has boosted its management team with the appointment of Michael Winlo as chief executive, ahead of an expected IPO later this year.
Loading
Thursday, 24 October, 2019 - 11:34
Emerald targets green medicine growth
With mainstream acceptance for cannabinoid medicines growing, Emerald Clinics has found value in building clinical evidence of its use.
Loading
Tuesday, 7 January, 2020 - 15:36
Medicinal cannabis IPOs seek $18m
Perth companies Emerald Clinics and Little Green Pharma are seeking to raise up to $18 million ahead of stock market listings as they pursue very different strategies in the medicinal cannabis market.
Loading
Tuesday, 11 February, 2020 - 14:11
Medical leaders selected to develop sector plan
The state government has appointed an industry reference group to develop a growth plan for WA’s health and medical life sciences sector to be chaired by Peter Klinken.
Loading
Tuesday, 11 February, 2020 - 15:33
Perth cannabis companies raise $16m from IPOs
Emerald Clinics and Little Green Pharma have both completed their initial public offerings ahead of stock market listings this month, with Emerald getting ready for its ASX debut tomorrow.
Loading
Monday, 14 September, 2020 - 08:00
More than Linear growth for drug trials in COVID-free WA
Perth’s largest drug testing company plans to nearly double capacity as WA attracts attention from global pharmaceutical companies.
Loading
Monday, 22 November, 2021 - 12:02
Forrest pitches in for cannabis research
Shares in Perth-based medicinal cannabis aspirant Emyria were up as much as 21 per cent after the business revealed a $5 million backing from Andrew Forrest’s investment business, Tattarang.
Loading
Thursday, 20 January, 2022 - 15:42
Emyria to begin cannabis trial
Andrew Forrest-backed Emyria is slated to start human clinical trials within weeks for a cannabinoid drug to treat psychological distress.
Loading
Monday, 7 November, 2022 - 09:20
Healthtech banks on rising numbers
The commercial side of life sciences may have reached a critical mass in WA.
Tuesday, 28 March, 2023 - 16:26
Board Moves March 28, 2023
Our board moves wrap includes Andrew Metcalfe, George Lazarou, María Claudia Pohl Ibáñez, Christopher Chalwell, Michael Winlo, Brett Crowley, Erlyn Dawson, and Aaron Brinkworth.
Loading
Thursday, 23 January, 2025 - 17:17
Board moves January 23, 2025
Today’s board moves wrap includes Michael Winlo, Greg Hutchinson, Stuart Mathews, Dennis Wilkins, Felicity Gooding, Matthew Horgan, Nitin Tyagi, Kaitlin Smith and Mark Pitts.

Turning innovative ideas into real-world outcomes
Monday, 8 August, 2016 - 15:37

Board Moves March 28, 2023
Tuesday, 28 March, 2023 - 16:26
TimelineJS
New CEO aims to grow Perkins subsidiary
Turning innovative ideas into real-world outcomes
Export awards show local diversity
A Linear approach to medical data
Linear recognised for global growth
Appointments July 11, 2019
Winlo joins Emerald Clinics
Emerald targets green medicine growth
Medicinal cannabis IPOs seek $18m
Medical leaders selected to develop sector plan
Perth cannabis companies raise $16m from IPOs
More than Linear growth for drug trials in COVID-free WA
Forrest pitches in for cannabis research
Emyria to begin cannabis trial
Healthtech banks on rising numbers
Board Moves March 28, 2023
Board moves January 23, 2025
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
2051
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
March
April
May
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Dec.
March
March

Related Information

Access to our data for Michael Winlo is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Michael Winlo is linked to 8 organisations which are included in 3 lists - Public Companies - non WA, Not For Profit Businesses and Public Companies - Industrial WA.

To see the data you will need to Subscribe.

Michael Winlo

Lists and Charts

Revenue

Revenue

Roles

Roles

Total Shareholder Return as at 02/12/24

Total Shareholder Return as at 02/12/24

Share Transactions

Share Transactions

Person Activity

Tuesday, 20 March, 2018 - 12:29

Biotech investment delivers boon to WA trial facility

Monday, 18 April, 2016 - 12:51

Monday, 8 August, 2016 - 15:37

Thursday, 3 November, 2016 - 14:13

Friday, 29 September, 2017 - 09:50

Friday, 8 December, 2017 - 14:06

Thursday, 11 July, 2019 - 15:53

Thursday, 3 October, 2019 - 10:53

Thursday, 24 October, 2019 - 11:34

Tuesday, 7 January, 2020 - 15:36

Tuesday, 11 February, 2020 - 14:11

Tuesday, 11 February, 2020 - 15:33

Monday, 14 September, 2020 - 08:00

Monday, 22 November, 2021 - 12:02

Thursday, 20 January, 2022 - 15:42

Monday, 7 November, 2022 - 09:20

Tuesday, 28 March, 2023 - 16:26

Thursday, 23 January, 2025 - 17:17

New CEO aims to grow Perkins subsidiary

Turning innovative ideas into real-world outcomes

Export awards show local diversity

A Linear approach to medical data

Linear recognised for global growth

Appointments July 11, 2019

Winlo joins Emerald Clinics

Emerald targets green medicine growth

Medicinal cannabis IPOs seek $18m

Medical leaders selected to develop sector plan

Perth cannabis companies raise $16m from IPOs

More than Linear growth for drug trials in COVID-free WA

Forrest pitches in for cannabis research

Emyria to begin cannabis trial

Healthtech banks on rising numbers

Board Moves March 28, 2023

Board moves January 23, 2025

Related Information